
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Keywords: MNK; MAP kinase-interacting kinase; TMZ; temozolomide; GBM; glioblastoma; MTC; medullary thyroid carcinoma; ERK; extracellular signal-regulated kinases; eIF4E/G1; eukaryotic translation initiation factor 4E/G1; MAPK; mitogen-activated protein kinase; GAPD